Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Early Out who wrote (433)	5/5/1998 6:54:00 PM
From: VLAD	of 1016

John, Thanks for sharing your thoughts. Evidently our opinions on MUSE are fairly opposite and that is OK. I don't expect Vivus stock to run up to 40 again any time soon but I still think that fair value is somewhere between $20-25.00/share which is why I bought in after December's crash. I think Viagra will bring in more new MUSE patients than it will take away. Remember all of last year Vivus did no advertising and there was no daily media hype over ED cures. As for your remark that men are afraid of pain-yes I agree when it comes to the needle but I still say that men have been too embarrassed to get help. As one urologist put it, before the media hype over Viagra, my patients would park their car 2 blocks away from the clinic and now they just drive right up to the front door. VLAD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next